Bioceptive
New Orleans, US · Founded 2011 · 2 known investors
Bioceptive develops women's health medical devices, including a patented FDA-approved Cervical Suction Retractor that replaces the tenaculum for gynecological procedures and an IUD inserter, offering single-use disposable instruments aimed at reducing pain during transcervical procedures. It serves healthcare professionals in the U.S. and developing regions, and is based in New Orleans, Louisiana.
Founders & leadership
SK
Shuchi KhuranaNamed on SEC filing
BC
Benjamin CappielloNamed on SEC filing
JH
John HardmanNamed on SEC filing
SD
Stewart DavisNamed on SEC filing
Board
JN
Joan NeuschelerBoard director
JL
Joseph LovettBoard director
AK
Amit Kumar RathiBoard director
OL
Orin LevyBoard director
VB
Vicki BriggsChair of the Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$456.4K disclosed across 2 rounds · 2012–2016
▶$416.4KraisedJan 2016 · 16 investors · BiotechnologyRule 506(b)
▶$416.4KraisedJan 2016 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joan NeuschelerDirector
- Joseph LovettDirector
- Amit Kumar RathiDirector
- Orin LevyDirector
- Shuchi KhuranaExecutive Officer
- Benjamin CappielloExecutive Officer, Director
- Offering amount
- $650K
- Amount sold
- $416.4K
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$40KraisedMar 2012 · 2 investors · OtherRule 506(b)
▶$40KraisedMar 2012 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin CappielloExecutive Officer, Director
- John HardmanDirector
- Stewart DavisExecutive Officer, Director
- Offering amount
- $250K
- Amount sold
- $40K
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Bioceptive do?
- Bioceptive develops women's health medical devices, including a patented FDA-approved Cervical Suction Retractor that replaces the tenaculum for gynecological procedures and an IUD inserter, offering single-use disposable instruments aimed at reducing pain during transcervical procedures. It serves healthcare professionals in the U.S. and developing regions, and is based in New Orleans, Louisiana.
- Who are Bioceptive's investors?
- Bioceptive's investors include Louisiana Funds, New Orleans Startup Fund.
- How much funding has Bioceptive raised?
- Bioceptive has disclosed $456.4K raised across 2 rounds.
- Where is Bioceptive headquartered?
- Bioceptive is headquartered in New Orleans, US.